Pricing Log in Create free account

Cingulate Inc. (CING) vs Nordicus Partners Corporation (NORD)

Cingulate Inc. and Nordicus Partners Corporation are both Biotechnology companies. Cingulate Inc. and Nordicus Partners Corporation are of similar size ($63.2M and $61.7M). Across the 10 metrics below, Nordicus Partners Corporation leads on 7 and Cingulate Inc. on 3.

Valuation

Metric CING NORD Biotechnology median
P/E n/m n/m 10.60
P/S n/m 77.00 9.40
P/B 2.39 1.00 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 79.49 9.02
Earnings yield (86.36%) (8.70%) (32.88%)
Free cash flow yield (37.28%) (6.60%) (23.13%)

Profitability

Metric CING NORD Biotechnology median
Gross margin 0.00% 70.18% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (198.74%) (8.06%) (51.96%)
Return on assets (123.76%) (6.80%) (46.06%)
Return on invested capital 0.00% (4.43%) 0.00%

Growth

Metric CING NORD Biotechnology median
Revenue growth (TTM) — (71.68%) 6.76%
EPS growth (last fiscal year) 59.12% 30.58% 29.88%
Revenue growth, 5-year CAGR — (71.31%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CING NORD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.50 0.18 4.97
Net debt to EBITDA 0.51 0.00 1.01

Dividend

Metric CING NORD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CING NORD Biotechnology median
Market cap 61.66m 63.19m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack